xconomy.com xconomy.com - La puntuación es 60/100

Revisión web de xconomy.com

 Generado el 15 Octubre 2026 13:45 PM

Resultados antiguos? ACTUALIZAR !

La puntuación es 60/100





Advertisement

Contenido SEO

Título

BioXconomy

Longitud : 10

Preferiblemente, tu título debería contener entre 40 y 70 caracteres (espacios incluidos). Usa esta herramienta gratuita para calcular la longitud del texto.

Descripción

BioXconomy provides information and insights for life sciences investment, innovation and partnering.

Longitud : 101

Genial, tu descripción meta contiene entre 90 y 160 caracteres.

Palabras Claves (Keywords)

Muy mal. No hemos encontrado palabras clave (meta keywords) en tu página. Usa este generador de meta tags gratuito para crear tus palabras clave.

Propiedades Meta Og

Bien. Tu página usa propiedades Og (etiquetas og).

Propiedad Contenido
title BioXconomy
description BioXconomy provides information and insights for life sciences investment, innovation and partnering.
url https://www.bioxconomy.com/
type website
image https://eu-images.contentstack.com/v3/assets/blt72fb3b8b4630b7db/blt25617c776391716f/6a7e58393f96871c9f61f984/BioXconomy-opengraph-2.jpg?disable=upscale&width=1200&height=630&fit=crop
site_name BioXconomy

Titulos

H1 H2 H3 H4 H5 H6
0 3 9 8 4 0
  • [H2] Latest News
  • [H2] Blood-brain barrier repair peptide could hold promise for ALS patients
  • [H2] Blood-brain barrier repair peptide could hold promise for ALS patients
  • [H3] IgniteData, RealTime eClinical Solutions announce data transfer partnership
  • [H3] OMass bags $310m to push rare disease drugs forward
  • [H3] Zealand Pharma generates metabolic therapeutics with AI platform
  • [H3] Bluesky and X users share clinical trial information in markedly different ways, new research shows
  • [H3] Dose of Discovery Podcast, Season 1
  • [H3] Watch the latest presentations coming from our recent partnering events
  • [H3] News from APAC
  • [H3] Interviews
  • [H3] AI in Life Sciences
  • [H4] Related Topics
  • [H4] Recent in Partnering
  • [H4] Related Topics
  • [H4] Recent in Investment
  • [H4] Related Topics
  • [H4] Recent in Modalities
  • [H4] Related Topics
  • [H4] Recent in Business Strategy
  • [H5] Resources
  • [H5] Connect
  • [H5] Join Us
  • [H5] Follow Us

Imagenes

Hemos encontrado 54 imágenes en esta web.

4 atributos alt están vacios o no existen. Agrega texto alternativo para que los motores de búsqueda puedan entender las imágenes.

Ratio Texto/HTML

Ratio : 3%

El ratio entre texto y código HTML de esta página es menor que el 20 por ciento, esto significa que tu web posiblemente necesite más contenido en texto.

Iframe

Muy mal, tienes Iframes en la página, esto significa que el contenido no podrá ser indexado.

Reescritura URL

Bien. Tus enlaces parecen amigables

Guiones bajos en las URLs

Perfecto! No hemos detectado guiones bajos en tus URLs

Enlaces en página

Hemos encontrado un total de 73 enlaces incluyendo 0 enlace(s) a ficheros

Ancla Tipo Jugo
Informa PLC Externo Pasando Jugo
ABOUT US Externo Pasando Jugo
INVESTOR RELATIONS Externo Pasando Jugo
TALENT Externo Pasando Jugo
About Interna Pasando Jugo
Events Interna Pasando Jugo
Advertise Externo Pasando Jugo
Licensing Interna Pasando Jugo
M&A Interna Pasando Jugo
Growth Strategy Interna Pasando Jugo
Partnering Interna Pasando Jugo
Zealand Pharma generates metabolic therapeutics with AI platform Interna Pasando Jugo
Nnenna Ohaka Interna Pasando Jugo
Danaher and NVIDIA partner on AI-driven lab automation Interna Pasando Jugo
Millie Nelson Interna Pasando Jugo
VC/PE Interna Pasando Jugo
Seed Funding Interna Pasando Jugo
IPOs Interna Pasando Jugo
Investment Interna Pasando Jugo
OMass bags $310m to push rare disease drugs forward Interna Pasando Jugo
Stryker bets big on robot surgery, backing CMR Surgical in $400m deal Interna Pasando Jugo
Nucleic Acids Interna Pasando Jugo
Antibodies and Peptides Interna Pasando Jugo
Advanced Therapies Interna Pasando Jugo
Modalities Interna Pasando Jugo
Rethinking Expression to Accelerate Antibody Discovery Interna Pasando Jugo
Blood-brain barrier repair peptide could hold promise for ALS patients Interna Pasando Jugo
Søren Hough Interna Pasando Jugo
Compliance, Regulatory and Legal Interna Pasando Jugo
Access and Channel Interna Pasando Jugo
Finance and Accounting Interna Pasando Jugo
Clinical Trials Interna Pasando Jugo
Pricing and Contracting Interna Pasando Jugo
Business Strategy Interna Pasando Jugo
Optimizing the Affordability Journey: Insights from a Real-World Brand Case Study Interna Pasando Jugo
IgniteData, RealTime eClinical Solutions announce data transfer partnership Interna Pasando Jugo
EMA to make EU-level trial advice pilot a permanent option for sponsors Interna Pasando Jugo
Dose of Discovery: Katalin Karikó on the mRNA breakthrough that changed medicine Interna Pasando Jugo
Dose of Discovery: Anne Conibear on how small changes reshape peptide and protein biology Interna Pasando Jugo
Dose of Discovery: Erik Sontheimer on the evolution of genome editing Interna Pasando Jugo
Dose of Discovery: Cheng Yi Chen on scaling drugs from lab to launch Interna Pasando Jugo
Dose of Discovery: Stanley Crooke on fixing nano-rare disease with oligos Interna Pasando Jugo
Dose of Discovery: Julia Alterman on expanding RNA therapeutics Interna Pasando Jugo
Dose of Discovery: Debut trailer Interna Pasando Jugo
Eyes on Asia: TCGX, Biohaven, Roche Interna Pasando Jugo
Shionogi bolsters rare disease portfolio with $2bn IntraBio buy Interna Pasando Jugo
The hidden cost of going global: How most favored nation pricing is reshaping rare disease launches Interna Pasando Jugo
Brandy Fidler Interna Pasando Jugo
SEC-FDA pact tightens disclosure rules for pharma Interna Pasando Jugo
Lisa Henderson Interna Pasando Jugo
Medtech firms embrace embedded digital compliance Interna Pasando Jugo
Tarn Brown Interna Pasando Jugo
DaltonTx announces AI breakthrough in novel antibody discovery Interna Pasando Jugo
Millie Hoe Interna Pasando Jugo
HHS launches initiative to bolster US clinical trials market Interna Pasando Jugo
Gareth Macdonald Interna Pasando Jugo
Protect IP theft from vast datasets used in AI Interna Pasando Jugo
Recruitment challenges, delays, and AI reshaping trials sector, survey finds Interna Pasando Jugo
Veeva unveils AI agent to speed clinical trial study configuration Interna Pasando Jugo
Rethinking biotech investment and innovation in a productivity-driven era Interna Pasando Jugo
Brick by brick: How AI-native biotechs are building investor confidence Interna Pasando Jugo
How AI is streamlining patient support behind the scenes Interna Pasando Jugo
AI drug hunter Iambic files for Nasdaq IPO Interna Pasando Jugo
Enveda’s $311m Series E to fund AI-driven drug discovery Interna Pasando Jugo
Webinars Interna Pasando Jugo
Podcasts Interna Pasando Jugo
Innovation Showcase Interna Pasando Jugo
Partner Videos Interna Pasando Jugo
Contribute Interna Pasando Jugo
About Informa Externo Pasando Jugo
Contact Informa Externo Pasando Jugo
Privacy Externo Pasando Jugo
Terms Externo Pasando Jugo
Advertisement

Palabras Clave SEO

Nube de Palabras Clave

playarrow      dose      discovery      now      lsx      chevronright      presents      min      read      oct     

Consistencia de las Palabras Clave

Palabra Clave (Keyword) Contenido Título Palabras Claves (Keywords) Descripción Titulos
oct 22
discovery 22
lsx 21
min 20
presents 19

Usabilidad

Url

Dominio : xconomy.com

Longitud : 11

Favicon

Genial, tu web tiene un favicon.

Idioma

Genial. Has declarado el idioma en.

Documento

Tipo de documento (Doctype)

HTML 5

Codificación

Perfecto. Has declarado como codificación UTF-8.

Privacidad de los Emails

Genial. No hay ninguna dirección de email como texto plano!

HTML obsoleto

Genial, no hemos detectado ninguna etiqueta HTML obsoleta.

Consejos de Velocidad

Muy mal, tu web está usando estilos embenidos (inline CSS).
Muy mal, tu página web usa demasiados ficheros CSS (más de 4).
Perfecto, tu web usa pocos ficheros JavaScript.
Su sitio web se beneficia del tipo de compresión gzip. ¡Perfecto!

Movil

Optimización Móvil

Icono para Apple
Etiqueta Meta Viewport
Advertisement

Optimización

Mapa del sitio XML

¡Perfecto! Su sitio tiene un mapa del sitio en XML.

https://www.bioxconomy.com/sitemap.xml
https://www.bioxconomy.com/googlenews.xml
https://www.bioxconomy.com/contributors.xml
https://www.bioxconomy.com/generic-content.xml
https://www.bioxconomy.com/image-archive-index.xml
https://www.bioxconomy.com/news-archive-index.xml
https://www.bioxconomy.com/event-archive-index.xml
https://www.bioxconomy.com/articles-archive-index.xml
https://www.bioxconomy.com/videos-archive-index.xml
https://www.bioxconomy.com/webinar-archive-index.xml
https://www.bioxconomy.com/podcast-archive-index.xml
https://www.bioxconomy.com/multi-section-article-archive-index.xml
https://www.bioxconomy.com/publication-issue-archive-index.xml
https://www.bioxconomy.com/document-archive-index.xml
https://www.bioxconomy.com/sitemap-index.xml
https://www.bioxconomy.com/ads.txt

Robots.txt

http://xconomy.com/robots.txt

¡Estupendo! Su sitio web tiene un archivo robots.txt.

Herramientas de Analítica

No disponible

No hemos encontrado ninguna herramienta de analítica en esta web.

La analítica Web le permite medir la actividad de los visitantes de su sitio web. Debería tener instalada al menos una herramienta de analítica y se recomienda instalar otra más para obtener una confirmación de los resultados.

AI Search Readiness

AI Crawlers

AI search crawlers are allowed, so the site can be shown and cited in AI answers (ChatGPT, Claude, Perplexity).

OAI-SearchBot ChatGPT search AI search
ChatGPT-User ChatGPT (user requests) AI search
Claude-SearchBot Claude search AI search
Claude-User Claude (user requests) AI search
PerplexityBot Perplexity AI search
GPTBot OpenAI training AI training
ClaudeBot Anthropic training AI training
Google-Extended Google Gemini training AI training
Applebot-Extended Apple AI training AI training
CCBot Common Crawl AI training

Blocking AI training crawlers is a common choice and doesn't affect the score. Only the AI search crawlers count.

Structured Data

The homepage describes itself with schema.org structured data, which helps search engines and AI tools understand it: NewsMediaOrganization, ImageObject, QuantitativeValue

Canonical Tag

The homepage has a canonical tag, which tells search engines which URL is the main version of the page.

llms.txt

No llms.txt file. It's an emerging convention: a short Markdown summary of the site for AI tools. Optional, so it doesn't affect the score.

Security

HTTPS

The site loads over HTTPS, so connections are encrypted. Browsers and search engines expect this.

HSTS

The site sends a Strict-Transport-Security header, so browsers always use HTTPS for it.

Security Headers

1 of 5 common security headers found. At least 2 are needed to pass.

Content-Security-Policy
X-Content-Type-Options
X-Frame-Options
Referrer-Policy
Permissions-Policy
Checked on 15 Oct 2026.

Domain Info

xconomy.com was registered on 25 Aug 2006 with SafeNames Ltd. and expires on 25 Aug 2027. It has no mail server (MX) records. The Wayback Machine first archived it in April 2001.

Registration

Registrar SafeNames Ltd.
Registered 25 Aug 2006 (20 years ago)
Expires 25 Aug 2027
Last changed 25 Aug 2026
Nameservers james.ns.cloudflare.com, marge.ns.cloudflare.com
DNSSEC Signed

Hosting

IPv4 address 172.67.128.87, 104.21.0.223
IPv6 support

Email Security

This domain has no mail server (MX) records, so it doesn't receive email.

SPF record
DMARC record (policy: quarantine)

Archive History

The Wayback Machine has snapshots of this site from 189 different months, from April 2001 to February 2026. View snapshots

Domain data checked on 15 Oct 2026. Sources: registry RDAP, public DNS, Internet Archive.

PageSpeed Insights


Dispositivo
Categorias

Advertisement

GoInfosystems

GoInfosystems es una herramienta seo gratuita que te ayuda a analizar tu web